Logo image of AOMR

ANGEL OAK MORTGAGE REIT INC (AOMR) Stock Fundamental Analysis

NYSE:AOMR - US03464Y1082 - REIT

9.86 USD
+0.16 (+1.65%)
Last: 8/29/2025, 8:06:30 PM
9.86 USD
0 (0%)
After Hours: 8/29/2025, 8:06:30 PM
Fundamental Rating

6

AOMR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. AOMR scores excellent on profitability, but there are concerns on its financial health. AOMR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

AOMR had positive earnings in the past year.
AOMR had a negative operating cash flow in the past year.
Of the past 5 years AOMR 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: AOMR reported negative operating cash flow in multiple years.
AOMR Yearly Net Income VS EBIT VS OCF VS FCFAOMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

AOMR has a Return On Assets of 1.46%. This is amongst the best in the industry. AOMR outperforms 89.55% of its industry peers.
The Return On Equity of AOMR (15.14%) is better than 100.00% of its industry peers.
AOMR's Return On Invested Capital of 0.75% is fine compared to the rest of the industry. AOMR outperforms 71.64% of its industry peers.
AOMR had an Average Return On Invested Capital over the past 3 years of 0.64%. This is in line with the industry average of 1.32%.
The 3 year average ROIC (0.64%) for AOMR is below the current ROIC(0.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.46%
ROE 15.14%
ROIC 0.75%
ROA(3y)-1.22%
ROA(5y)-0.54%
ROE(3y)-18.1%
ROE(5y)-9.94%
ROIC(3y)0.64%
ROIC(5y)1.32%
AOMR Yearly ROA, ROE, ROICAOMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

AOMR's Profit Margin of 95.86% is amongst the best of the industry. AOMR outperforms 100.00% of its industry peers.
AOMR's Profit Margin has improved in the last couple of years.
AOMR has a better Operating Margin (56.29%) than 94.03% of its industry peers.
AOMR's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 89.51%, AOMR belongs to the best of the industry, outperforming 98.51% of the companies in the same industry.
AOMR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 56.29%
PM (TTM) 95.86%
GM 89.51%
OM growth 3Y-9.35%
OM growth 5Y2.62%
PM growth 3Y21.67%
PM growth 5Y12.2%
GM growth 3Y-3.55%
GM growth 5Y2.48%
AOMR Yearly Profit, Operating, Gross MarginsAOMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, AOMR has less shares outstanding
AOMR has less shares outstanding than it did 5 years ago.
AOMR has a worse debt/assets ratio than last year.
AOMR Yearly Shares OutstandingAOMR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
AOMR Yearly Total Debt VS Total AssetsAOMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

AOMR has an Altman-Z score of -0.15. This is a bad value and indicates that AOMR is not financially healthy and even has some risk of bankruptcy.
AOMR has a Altman-Z score (-0.15) which is comparable to the rest of the industry.
A Debt/Equity ratio of 8.29 is on the high side and indicates that AOMR has dependencies on debt financing.
AOMR's Debt to Equity ratio of 8.29 is on the low side compared to the rest of the industry. AOMR is outperformed by 79.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.29
Debt/FCF N/A
Altman-Z -0.15
ROIC/WACCN/A
WACCN/A
AOMR Yearly LT Debt VS Equity VS FCFAOMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

AOMR has a Current Ratio of 0.14. This is a bad value and indicates that AOMR is not financially healthy enough and could expect problems in meeting its short term obligations.
AOMR has a Current ratio (0.14) which is in line with its industry peers.
A Quick Ratio of 0.14 indicates that AOMR may have some problems paying its short term obligations.
AOMR's Quick ratio of 0.14 is in line compared to the rest of the industry. AOMR outperforms 44.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
AOMR Yearly Current Assets VS Current LiabilitesAOMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

AOMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.00%, which is quite impressive.
Measured over the past years, AOMR shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.43% on average per year.
AOMR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.48%.
AOMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.67% yearly.
EPS 1Y (TTM)195%
EPS 3Y11.75%
EPS 5Y42.43%
EPS Q2Q%222.22%
Revenue 1Y (TTM)15.48%
Revenue growth 3Y-9.05%
Revenue growth 5Y25.67%
Sales Q2Q%5.04%

3.2 Future

AOMR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.61% yearly.
AOMR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.81% yearly.
EPS Next Y199.2%
EPS Next 2Y115.82%
EPS Next 3Y69.61%
EPS Next 5YN/A
Revenue Next Year13.05%
Revenue Next 2Y13.4%
Revenue Next 3Y6.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AOMR Yearly Revenue VS EstimatesAOMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
AOMR Yearly EPS VS EstimatesAOMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 2 -2

6

4. Valuation

4.1 Price/Earnings Ratio

AOMR is valuated rather expensively with a Price/Earnings ratio of 17.30.
Compared to the rest of the industry, the Price/Earnings ratio of AOMR is on the same level as its industry peers.
AOMR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.08.
Based on the Price/Forward Earnings ratio of 7.06, the valuation of AOMR can be described as very cheap.
88.06% of the companies in the same industry are more expensive than AOMR, based on the Price/Forward Earnings ratio.
AOMR is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.3
Fwd PE 7.06
AOMR Price Earnings VS Forward Price EarningsAOMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AOMR Per share dataAOMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

AOMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of AOMR may justify a higher PE ratio.
A more expensive valuation may be justified as AOMR's earnings are expected to grow with 69.61% in the coming years.
PEG (NY)0.09
PEG (5Y)0.41
EPS Next 2Y115.82%
EPS Next 3Y69.61%

4

5. Dividend

5.1 Amount

AOMR has a Yearly Dividend Yield of 12.90%, which is a nice return.
AOMR's Dividend Yield is comparable with the industry average which is at 12.25.
Compared to an average S&P500 Dividend Yield of 2.34, AOMR pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.9%

5.2 History

AOMR has been paying a dividend for over 5 years, so it has already some track record.
AOMR has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
AOMR Yearly Dividends per shareAOMR Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AOMR pays out 80.90% of its income as dividend. This is not a sustainable payout ratio.
DP80.9%
EPS Next 2Y115.82%
EPS Next 3Y69.61%
AOMR Yearly Income VS Free CF VS DividendAOMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B
AOMR Dividend Payout.AOMR Dividend Payout, showing the Payout Ratio.AOMR Dividend Payout.PayoutRetained Earnings

ANGEL OAK MORTGAGE REIT INC

NYSE:AOMR (8/29/2025, 8:06:30 PM)

After market: 9.86 0 (0%)

9.86

+0.16 (+1.65%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners73.81%
Inst Owner Change-4.49%
Ins Owners4.53%
Ins Owner Change0.67%
Market Cap234.37M
Analysts81.54
Price Target12.16 (23.33%)
Short Float %0.79%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 12.9%
Yearly Dividend1.28
Dividend Growth(5Y)N/A
DP80.9%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-22 2025-08-22 (0.32)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.4%
Min EPS beat(2)-62.25%
Max EPS beat(2)-38.54%
EPS beat(4)1
Avg EPS beat(4)-50.48%
Min EPS beat(4)-155.27%
Max EPS beat(4)54.14%
EPS beat(8)1
Avg EPS beat(8)-129.64%
EPS beat(12)2
Avg EPS beat(12)-194.28%
EPS beat(16)3
Avg EPS beat(16)-170.52%
Revenue beat(2)0
Avg Revenue beat(2)-12.12%
Min Revenue beat(2)-13.49%
Max Revenue beat(2)-10.75%
Revenue beat(4)0
Avg Revenue beat(4)-10.82%
Min Revenue beat(4)-13.49%
Max Revenue beat(4)-8.23%
Revenue beat(8)0
Avg Revenue beat(8)-10.1%
Revenue beat(12)0
Avg Revenue beat(12)-19.59%
Revenue beat(16)1
Avg Revenue beat(16)-19.22%
PT rev (1m)0%
PT rev (3m)5.15%
EPS NQ rev (1m)-10.52%
EPS NQ rev (3m)-13.96%
EPS NY rev (1m)-20%
EPS NY rev (3m)-24.14%
Revenue NQ rev (1m)-4.02%
Revenue NQ rev (3m)-8.64%
Revenue NY rev (1m)-4.45%
Revenue NY rev (3m)-9.98%
Valuation
Industry RankSector Rank
PE 17.3
Fwd PE 7.06
P/S 6.02
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.57
EY5.78%
EPS(NY)1.4
Fwd EY14.17%
FCF(TTM)-17.61
FCFYN/A
OCF(TTM)-17.61
OCFYN/A
SpS1.64
BVpS10.37
TBVpS10.37
PEG (NY)0.09
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 15.14%
ROCE 0.98%
ROIC 0.75%
ROICexc 0.77%
ROICexgc 0.77%
OM 56.29%
PM (TTM) 95.86%
GM 89.51%
FCFM N/A
ROA(3y)-1.22%
ROA(5y)-0.54%
ROE(3y)-18.1%
ROE(5y)-9.94%
ROIC(3y)0.64%
ROIC(5y)1.32%
ROICexc(3y)0.65%
ROICexc(5y)1.4%
ROICexgc(3y)0.66%
ROICexgc(5y)1.4%
ROCE(3y)0.85%
ROCE(5y)2.27%
ROICexcg growth 3Y-10.97%
ROICexcg growth 5Y-4.36%
ROICexc growth 3Y-11.11%
ROICexc growth 5Y-4.49%
OM growth 3Y-9.35%
OM growth 5Y2.62%
PM growth 3Y21.67%
PM growth 5Y12.2%
GM growth 3Y-3.55%
GM growth 5Y2.48%
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 8.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.3
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z -0.15
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195%
EPS 3Y11.75%
EPS 5Y42.43%
EPS Q2Q%222.22%
EPS Next Y199.2%
EPS Next 2Y115.82%
EPS Next 3Y69.61%
EPS Next 5YN/A
Revenue 1Y (TTM)15.48%
Revenue growth 3Y-9.05%
Revenue growth 5Y25.67%
Sales Q2Q%5.04%
Revenue Next Year13.05%
Revenue Next 2Y13.4%
Revenue Next 3Y6.81%
Revenue Next 5YN/A
EBIT growth 1Y41.15%
EBIT growth 3Y-17.55%
EBIT growth 5Y28.96%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-171.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-171.51%
OCF growth 3YN/A
OCF growth 5YN/A